http://qant.as/themaneevent Meet Ben,
Liam, Scott and Andrew. They\'re here to follow the British and Irish
Lions as they V Qantas Wallabies for the 2013 Tour. They
are also here to represent England, Ireland, Scotland and Wales in the
\'Mane Event\' challenge. Can these four Brits beats the Aussie in a game
of brains and brawn?
DIY Network® heads north to New England and the shores of beautiful Lake Champlain for the first-ever Ultimate Retreat, which has been reimagined after ten successful years as DIY Network Blog Cabin. The new project invites viewers to follow the demolition and renovation process room by room as a home in a spectacular vacation destination is transformed into a show-stopping retreat. Beginning today, fans can take a virtual tour of this cozy wooded escape in Burlington, Vermont to see what authentic waterside living is all about.
From Monday, August 7, fans can enter the sweepstakes each day through 5 p.m. ET Wednesday, September 27 for a chance to win the DIY Network Ultimate Retreat™ Giveaway 2017, including the fully furnished and completely renovated residence plus $50,000 from national mortgage lender Quicken Loans®.
To view the multimedia release go to:
https://www.multivu.com/players/English/8041052-diy-network-ultimate-retreat-2017-vermont/
Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE.
To view the multimedia release go to:
https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
The science of bionics helped the more than 1 million Americans with leg amputations take a giant step forward, as the Rehabilitation Institute of Chicago (RIC) revealed clinical applications for the world’s first thought-controlled bionic leg in this week’s New England Journal of Medicine. This innovative technology represents a significant milestone in the rapidly-growing field of bionics. Until now, only thought-controlled bionic arms were available to amputees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63339-rehabilitation-institute-of-chicago-first-thought-controlled-bionic-leg
Death Be Not Proud is the thrilling second installment in The Secret of the Journal series. Professor Emma D’Eresby flees her teaching position in Maine after a vicious attack by a psychotic colleague, but mysterious secrets and suspense still follow her back to her hometown in England. Learn more about this book here, http://bit.ly/1aLIAPr Romantic Thriller
Since Newton witnessed a bubble rising from his bathtub, mankind has sought the stars. When William III of England commissioned Capt. William Kidd to command the first expedition to Mars in the late 1600s, he proved that space travel was both possible and profitable. Find out more at http://us.macmillan.com/arabellaofmars/daviddlevine-1 Arabella of Mars by David E Levine. Fantasy
